NEW ROUND OF ALLIANCE FUNDING APPROVED FOR NCI's Cancer Nanotechnology


The NCI's Scientific Program Leaders and Board of Scientific Advisors have approved the continuation of NCI’s Cancer Nanotechnology
Program for another 5 year period with initial awards to be made in September 2015.
The components of the program will be funded through following announcements:
Centers of Cancer Nanotechnology Excellence (U54) with set aside of $12-13M/year for 5-6 CCNEs.
Cancer Nanotechnology Research Platforms (U01). There will be multiple receipt dates for this Announcement.
Nanotechnology Research Training Programs (T32) supported with designated funds of $2M/year for five years. Proposals will be received through PA-14-015, with 1st receipt date of September 25, 2014.

Learn more about the Alliance's current programs and other research funding opportunities.

For more information about the Alliance, please contact:
NCI Office of Cancer Nanotechnology Research (OCNR)
National Cancer Institute
Center for Strategic Scientific Initiatives
Building 31, Room 10A52
31 Center Drive, MSC 2580
Bethesda, MD 20892-2580
Telephone: (301) 451-8983
Email: cancer.nano@mail.nih.gov

For information on NCI clinical trials now accepting participants, please visit: http://www.cancer.gov/clinicaltrials or contact the NIH Clinical Center directly at 1-888-NCI-1937 (1-888-624-1937) to be connected to a referral coordinator appropriate for your diagnosis. For media inquiries, please contact:
NCI Press Officers
Phone: (301) 496-6641
Fax: (301) 451-7440
E-mail: ncipressofficers@mail.nih.gov
For general information or to seek help, please visit:
www.cancer.gov or call NCI's Cancer Information Services at
1-800-4-CANCER (1-800-422-6237)

Recent publications of Nanotechnology in Cancer

Perspectives and potential applications of nanomedicine in breast and prostate cancer.
Liu Y, Solomon M, Achilefu S. Med Res Rev. 2013 Jan;33(1):3-32. doi: 10.1002/med.20233. Epub 2010 Nov 9. Review.

Using functional nanomaterials to target and regulate the tumor microenvironment: diagnostic and therapeutic applications.
Ji T, Zhao Y, Ding Y, Nie G. Adv Mater. 2013 Jul 12;25(26):3508-25. doi: 10.1002/adma.201300299. Epub 2013 May 24. Review.

Nanotechnological selection.
Demming A. Nanotechnology. 2013 Jan 18;24(2):020201. doi: 10.1088/0957-4484/24/2/020201. Epub 2012 Dec 14.

Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics.
Santhosh PB, Ulrih NP.. Cancer Lett. 2013 Aug 9;336(1):8-17. doi: 10.1016/j.canlet.2013.04.032. Epub 2013 May 7. Review.

Near-infrared light-mediated nanoplatforms for cancer thermo-chemotherapy and optical imaging.
Zhang Z, Wang J, Chen C. Adv Mater. 2013 Jul 26;25(28):3869-80. doi: 10.1002/adma.201301890. Epub 2013 Jun 6. Review.

Emerging applications of nanomedicine in dermatology.
Saraceno R, Chiricozzi A, Gabellini M, Chimenti S. Skin Res Technol. 2013 Feb;19(1):e13-9. doi: 10.1111/j.1600-0846.2011.00601.x. Epub 2011 Dec 18. Review.

Nanooncology: the future of cancer diagnosis and therapy.
Thakor AS, Gambhir SS. CA Cancer J Clin. 2013 Nov-Dec;63(6):395-418. doi: 10.3322/caac.21199. Epub 2013 Oct 1. Review.

Identification and usage of fluorescent probes as nanoparticle contrast agents in detecting cancer.
Murahari MS, Yergeri MC. Curr Pharm Des. 2013;19(25):4622-40. Review.

Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications.
Rizzo LY, Theek B, Storm G, Kiessling F, Lammers T.Curr Opin Biotechnol. 2013 Dec;24(6):1159-66. doi: 10.1016/j.copbio.2013.02.020. Epub 2013 Apr 9. Review.

Nanotheranostics of circulating tumor cells, infections and other pathological features in vivo.
Kim JW, Galanzha EI, Zaharoff DA, Griffin RJ, Zharov VP.Mol Pharm. 2013 Mar 4;10(3):813-30. doi: 10.1021/mp300577s. Epub 2013 Feb 25. Review. PMID: 23379366 [PubMed - indexed for MEDLINE] Free PMC Article

Targeted therapy using nanotechnology: focus on cancer.
Sanna V, Pala N, Sechi M. Int J Nanomedicine. 2014 Jan 15;9:467-83. doi: 10.2147/IJN.S36654. eCollection 2014. PMID: 24531078 [PubMed - in process] Free PMC Article

Nanoarchitectonics in cancer therapy and imaging diagnosis.
Pandey AP, Girase NM, Patil MD, Patil PO, Patil DA, Deshmukh PK. J Nanosci Nanotechnol. 2014 Jan;14(1):828-40. Review.